Top Markets
#1 ADO Protocol ADO Protocol +195.10%
#2 Islamic Coin Islamic Coin +155.35%
#3 GoPlus Security GoPlus Security +54.44%
#4 GAIB AID GAIB AID +24.67%
#5 Starpower Starpower +22.00%
#6 Verus Coin Verus Coin +13.54%
#7 Tutorial Tutorial +12.72%
#8 Casper Network Casper Network +12.03%
#9 SkyAI SkyAI +11.78%
#10 Pons Pons +11.75%
Coin of the day
ADO Protocol ADO Protocol
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Bharat Immunologicals & Biologicals Corporation Limited Bharat Immunologicals & Biologicals Corporation Limited

Bharat Immunologicals & Biologicals Corporation Limited

BIBCL
Rang in Aktien #33476
Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology... Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology enterprise, primarily involved in the development and manufacture of pharmaceutical goods. Its offerings include vital products such as oral polio vaccines, zinc tablets, comprehensive diarrhea management kits, and ready-to-consume therapeutic foods. The firm organizes its operations into several key divisions: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. Founded on March 10, 1989, the company's main office is situated in Bulandshahr, India.
Aktienkurs
$0.17558081
Marktkapitalisierung
$7.58M
Veränderung (1 Tag)
-0.25%
Veränderung (1 Jahr)
-30.30%
Land
IN
Handel Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)

Kategorie

Healthcare
P/S-Verhältnis für Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Bharat Immunologicals & Biologicals Corporation Limited beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Bharat Immunologicals & Biologicals Corporation Limited von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US